FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
Clinical trial NCT04768686 · COMPLETED
Trial details
- NCT number
- NCT04768686
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2024-08-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.